Role of magnetic resonance spectroscopy in grading of gliomas- a tertiary care centre study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20220279Keywords:
Cho/Cr, Cho/NAA, Glioma grading, MR spectroscopyAbstract
Background: Grading of gliomas is important for the determination of appropriate treatment strategies. MR spectroscopy has found increasing utility in grading of gliomas.
Methods: MR spectroscopic imaging was done for the referred patients to obtain Cho/NAA and Cho/Cr ratios. After analyzing histopathology reports, gliomas were classified into low grade and high grade. Histologically proven 54 low grade and 54 high grade gliomas were included in the study. The mean and standard deviation of these variables were obtained and compared between two groups. ROC curve analyses were performed in order to identify the optimal cut-off value for metabolite ratios for prediction purposes of high grade versus low grade gliomas.
Results: The mean and SD of Cho/NAA ratio in low grade glioma was 1.93±1.19. The mean and SD of Cho /NAA ratio in high grade glioma was 3.16±1.73 was significantly higher. The optimal cut-off for differentiating low grade and high grade gliomas was 2.15 with a sensitivity of 74.07% and specificity of 66.67%. The mean and SD of CHO/Cr in low grade glioma was 2.05±0.76. The mean and SD of Cho/NAA in high grade glioma was 2.87±1.65 was significantly higher. The optimal cut-off for differentiating low grade and high grade gliomas was 1.98 with a sensitivity of 64.8% and specificity of 64.1%.
Conclusions: MR spectroscopy imaging plays a pivotal role in prediction of glioma grade preoperatively and helps in deciding appropriate treatment strategies.
References
Scheau C, Preda E, Popa G, Ghergus A, Capsa R, Lupescu I. Magnetic resonance spectroscopy- a non-invasive method in evaluating focal and diffuse central nervous system disease. J Med Life. 2012;5(4):423-7.
Osborn AG, Hedlund G, Salzman KL. Osborn’s Brain. 2nd edn. Elsevier; 2017.
Khalid L, Carone M, Dumrongpisutikul N, Intrapiromkul J, Bonekamp D, Barker PB, et al. Imaging characteristics of oligodendrogliomas that predict grade. Am J Neuroradiol. 2012;33(5):852-7.
Korfiatis P, Erickson B. The basics of diffusion and perfusion imaging in brain tumors. Appl Radiol. 2014;43(7):22-9.
Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med. 1990;14(2):249-65.
Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol. 2003;24(10):1989-98
Deelchand DK, Van de Moortele PF, Adriany G, Iltis I, Andersen P, Strupp JP, et al. In Vivo 1H NMR Spectroscopy of the Human Brain at 9.4 Tesla: Initial Results. J Magn Reson San Diego Calif. 2010;206(1):74-80.
Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AMA. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 2007;81(2):89-131.
Lu D, Pavlakis SG, Frank Y, Bakshi S, Pahwa S, Gould RJ, et al. Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. Radiology. 1996;199(2):423-8.
Chang L, McBride D, Miller BL, Cornford M, Booth RA, Buchthal SD, et al. Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors. J Neuroimag. 1995;5(3):157-63.
Kim JH, Chang KH, Na DG, Song IC, Kwon BJ, Han MH, et al. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences. Am J Neuroradiol. 2006;27(7):1412-8.
Horská A, Barker PB. Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimag Clin N Am. 2010;20(3):293-310.
Scheau C, Preda E, Popa G, Ghergus A, Capsa R, Lupescu I. Magnetic resonance spectroscopy- a non-invasive method in evaluating focal and diffuse central nervous system disease. J Med Life. 2012;5(4):423-7.
Möller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology. 2002;44(5):371-81.
